Table 1

Characteristics of patients who underwent resection for colon cancer, by use of any glucocorticoids, Denmark, 2001–2011

CharacteristicsColon cancer
No glucocorticoid use, N=14 041
n (%)
Glucocorticoid use, N=4149
n (%)
p Value
Sex0.000
 Female7122 (50.7)2369 (57.1)
 Male6919 (49.3)1780 (42.9)
Age, years0.000
 <602399 (17.1)482 (11.6)
 60–693841 (27.4)949 (22.9)
 70–794688 (33.4)1582 (38.1)
 80+3113 (21.2)1136 (27.4)
Year of resection0.000
 2001–20044767 (34.0)1074 (25.9)
 2005–20085327 (37.9)1642 (39.6)
 2009–20113947 (28.1)1433 (34.5)
Stage0.001
 Localised7192 (51.2)2261 (54.5)
 Non-localised6510 (46.4)1785 (43.0)
 Unknown339 (2.4)103 (2.5)
CCI score0.001
 08557 (60.9)1448 (34.9)
 1–24074 (29.0)1812 (43.7)
 3+1410 (10.0)889 (21.4)
ASA score0.000
 ≤210 616 (75.6)2575 (62.1)
 >22812 (20.0)1420 (34.2)
 Unknown613 (4.4)154 (3.7)
IBD91 (0.7)108 (2.6)0.000
Autoimmune disorders or immunosuppressive drug use90 (0.6)256 (6.2)0.000
Obesity405 (2.9)208 (5.0)0.000
Alcoholism488 (3.5)159 (3.8)0.276
Tobacco use0.000
 Current use2088 (14.9)563 (13.6)
 Former use4159 (29.6)1429 (34.4)
 Never use3569 (25.4)898 (21.6)
 Unknown4225 (30.1)1259 (30.3)
NSAIDs3337 (23.8)1180 (28.4)0.000
COPD medications1547 (11.0)2404 (57.9)0.000
Surgical urgency0.190
 Planned12 140 (86.5)3617 (87.2)
 Acute1894 (13.5)532 (12.8)
 Unknown7 (0.1)0 (0.0)
Surgical approach0.004
 Laparoscopy3446 (24.5)1111 (26.8)
 Laparotomy10 595 (75.5)3038 (73.2)
Surgical procedure0.000
 Ileocaecal resection45 (0.3)8 (0.2)
 Right-sided hemicolectomy6925 (49.3)2239 (54.0)
 Transverse colon resection356 (2.5)101 (2.4)
 Left-sided hemicolectomy1546 (11.0)447 (10.8)
 Sigmoid colon resection4791 (34.1)1238 (29.8)
 Other resections15 (0.1)8 (0.2)
 Colectomy and IRA363 (2.6)108 (2.6)
 Rectal resection
Perioperative blood transfusion0.000
 Yes3312 (23.6)1120 (27.0)
 No10 611 (75.6)2999 (72.3)
 Missing/unknown118 (0.8)30 (0.7)
  • ASA, American Society of Anesthesiologists’ Physical Status Classification; CCI, Charlson Comorbidity Index; COPD, chronic obstructive pulmonary disease; CRC, colorectal cancer; IBD, inflammatory bowel disease; IRA, ileorectal anastomosis; NSAIDs, non-steroidal anti-inflammatory drugs.